Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/13/25 17:30 | 2/11/25 | FTRE | Health | Health | Medical Laboratories | Morais Mark A. | NC | O | COO | 5 | M.d | 18 | 3.48 | 0 | 5 | 18 | 34 | D | ||||||||||||||
2/13/25 17:30 | 2/12/25 | FTRE | Health | Health | Medical Laboratories | Morais Mark A. | NC | O | COO | 5 | S.d | -18 | 3.48 | 0 | -5 | 34 | D | |||||||||||||||
2/13/25 17:28 | 2/11/25 | FTRE | Health | Health | Medical Laboratories | McConnell Jill G. | NC | O | CFO | 4 | M.d | 16 | 3.79 | 0 | 4 | 14 | 35 | D | ||||||||||||||
2/13/25 17:28 | 2/12/25 | FTRE | Health | Health | Medical Laboratories | McConnell Jill G. | NC | O | CFO | 4 | S.d | -16 | 3.79 | 0 | -4 | 35 | D | |||||||||||||||
1/14/25 18:08 | 1/10/25 | FTRE | Health | Health | Medical Laboratories | Pike Thomas | NC | DO | CEO | 2 | M.d | 203 | 3.95 | 0 | 51 | 48 | 160 | D | ||||||||||||||
1/14/25 18:08 | 1/13/25 | FTRE | Health | Health | Medical Laboratories | Pike Thomas | NC | DO | CEO | 2 | S.d | -203 | 3.95 | 0 | -51 | 160 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |